Skip to main content
SPTX logo

Seaport Therapeutics, Inc.

SPTXNASDAQHealthcareBiotechnology

$17.83Today:- (-)

As of Oct 16, 2026 close

Market cap
$621.21M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$14.85$28.38
Volume (live)
-
Avg. volume (3M)
274.30K

Seaport Therapeutics (SPTX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Seaport Therapeutics reported total assets of $249.01M and total liabilities of $341.55M. Shareholders' equity was negative at −$92.55M, meaning liabilities exceed assets. Total debt stood at $5.08M against $215.98M in cash and short-term investments, a net cash position of $210.90M.

Seaport Therapeutics Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Seaport Therapeutics, Inc. (SPTX) - Annual data in millions USD
BreakdownFY 2025FY 2024
Period endingDec 2025Dec 2024
Current Assets
Cash and Cash Equivalents46.04309.10
Short-Term Investments169.94-
Cash & Short-Term Investments215.98309.10
Accounts Receivable3.03-
Inventory0.00-
Other Current Assets4.221.05
Total Current Assets223.23310.15
Non-Current Assets
Property, Plant & Equipment (Net)5.235.17
Long-Term Investments17.67-
Other Non-Current Assets2.880.45
Total Non-Current Assets25.785.63
Total Assets249.01315.78
Current Liabilities
Accounts Payable2.014.73
Short-Term Debt1.64-
Accrued Liabilities3.942.29
Other Current Liabilities9.14-
Total Current Liabilities12.7811.15
Non-Current Liabilities
Long-Term Debt3.444.15
Other Non-Current Liabilities325.33-
Total Non-Current Liabilities328.77329.48
Total Liabilities341.55340.63
Stockholders' Equity
Common Stock0.000.00
Retained Earnings-114.11-39.23
Accumulated Other Comprehensive Income0.30-
Additional Paid-in Capital21.2614.38
Shares Outstanding53.0353.03
Total Stockholders' Equity-92.55-24.85
Total Liabilities & Equity249.01315.78

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Seaport Therapeutics Balance Sheet

How much debt does Seaport Therapeutics have?

Seaport Therapeutics had total debt of $5.08M as of Dec 31, 2025, against $215.98M in cash and short-term investments. Total debt was $4.15M a year earlier.

What are Seaport Therapeutics's total assets?

Seaport Therapeutics reported total assets of $249.01M as of Dec 31, 2025, down 21.1% from $315.78M a year earlier. Total liabilities were $341.55M.

What is Seaport Therapeutics's shareholders' equity?

Seaport Therapeutics's shareholders' equity was negative at −$92.55M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition